4-[[5-(4-fluorophenyl)-6-(1-hydroxycyclopropyl)-1H-pyrazolo[4,3-g]isoquinolin-8-yl]oxy]benzoic acid
C26H18FN3O4 — CID 156879497
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[5-(4-fluorophenyl)-6-(1-hydroxycyclopropyl)-1H-pyrazolo[4,3-g]isoquinolin-8-yl]oxy]benzoic acid
4-[[5-(4-fluorophenyl)-6-(1-hydroxycyclopropyl)-1H-pyrazolo[4,3-g]isoquinolin-8-yl]oxy]benzoic acid (PubChem CID 156879497) has the molecular formula C26H18FN3O4 and a molecular weight of 455.45 g/mol. Its IUPAC name is 4-[[5-(4-fluorophenyl)-6-(1-hydroxycyclopropyl)-1H-pyrazolo[4,3-g]isoquinolin-8-yl]oxy]benzoic acid.
Molecular Properties
| Compound Name | 4-[[5-(4-fluorophenyl)-6-(1-hydroxycyclopropyl)-1H-pyrazolo[4,3-g]isoquinolin-8-yl]oxy]benzoic acid |
|---|---|
| PubChem CID | 156879497 |
| Molecular Formula | C26H18FN3O4 |
| Molecular Weight | 455.45 g/mol |
| Exact Mass | 455.13 |
| IUPAC Name | 4-[[5-(4-fluorophenyl)-6-(1-hydroxycyclopropyl)-1H-pyrazolo[4,3-g]isoquinolin-8-yl]oxy]benzoic acid |
| SMILES | O=C(O)c1ccc(Oc2nc(C3(O)CC3)c(-c3ccc(F)cc3)c3cc4cn[nH]c4cc23)cc1 |
| InChI | InChI=1S/C26H18FN3O4/c27-17-5-1-14(2-6-17)22-19-11-16-13-28-30-21(16)12-20(19)24(29-23(22)26(33)9-10-26)34-18-7-3-15(4-8-18)25(31)32/h1-8,11-13,33H,9-10H2,(H,28,30)(H,31,32) |
| InChIKey | WAXZQMBSEJCLQG-UHFFFAOYSA-N |
| XLogP | 5.39 |
| TPSA | 108.33 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 455.45 |
| LogP ≤ 5 | 5.39 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156879497 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.